MTOR and anemia (phenotype): Currently, mTOR inhibitors have been applied to treat several types of illnesses, including cancer, arteriosclerosis, and autoimmune diseases; however, numerous proinflammatory side effects have been observed, including interstitial pneumonitis, glomerulonephritis with proteinuria, lymphocytic alveolitis, and anemia [36-39].